Advertisement

Science China Life Sciences

, Volume 62, Issue 1, pp 46–62 | Cite as

A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

  • Zekai Wu
  • Tianru Jin
  • Jianping WengEmail author
Review

Abstract

The prevalence of diabetes has increased dramatically over the past three decades, and currently, China has the largest number of diabetics worldwide; this number continues to grow and puts ongoing strains on the medical resources. In this review, we reviewed the diabetes research conducted in China from 1995 to 2015 with the aim of providing new insights regarding the current status and future perspectives for researchers, diabetes health providers, and respective policy-makers. Remarkable progress has been made in diabetes research in China during the past two decades in terms of both the quantity and publication influence. The progress, however, struggles to adequately manage diabetes in China. Here we addressed opportunities to strengthen researches, including new drug development, high quality studies on health economics, and healthcare quality improvement studies. As the expected wave of diabetic complications is upcoming and overwhelming, we therefore recommend that immediate improvements are required to implement the researches regarding their prevention and treatment.

Keywords

diabetes publication number publication influence clinical research basic research traditional Chinese medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

We thank Yang Zhang from School of Information Management, Sun Yat-Sen University; Xuyu Zhou from Sun Yat-Sen University Library; Daoyuan Wang from AME Publishing Company; Wenbin Yang and Ling Tong from Sanofi Aventis for their contribution in suggestion on methodology. This work was supported by the National Key Research and Development Program of China (2017YFC1309600) and the National Health and Family Planning Commission Foundation for Public Welfare Industry Research Project (201502011).

Supplementary material

11427_2018_9377_MOESM1_ESM.pdf (1.1 mb)
Supplementary material, approximately 1.14 MB.

References

  1. American Diabetes Association, (2010). Standards of medical care in diabetes—2010. Diabetes Care 33, S11–S61.Google Scholar
  2. Bao, Y., Ma, X., Li, H., Zhou, M., Hu, C., Wu, H., Tang, J., Hou, X., Xiang, K., and Jia, W. (2010). Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340, c2249.Google Scholar
  3. Bennett, C., Guo, M., and Dharmage, S. (2007). HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 24, 333–343.Google Scholar
  4. Chen, A., Huang, Z., Wan, X., Deng, W., Wu, J., Li, L., Cai, Q., Xiao, H., and Li, Y. (2012). Attitudes toward diabetes affect maintenance of drugfree remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment. Diabetes Care 35, 474–481.Google Scholar
  5. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997–1006.Google Scholar
  6. Chinese Diabetes Society. China Guideline For Diabetes (2007 Ed) (in Chinese). (2008). Zhonghua Yi Xue Za Zhi 88, 1227–1245.Google Scholar
  7. Chinese Diabetes Society. China Guideline for Type 1 Diabetes-2011 (in Chinese). https://doi.org/www.diab.net.cn/uploadfile/ueditor/file/20160811/636-0650788212125003136602.pdf, 2017-07-01.
  8. Chinese Diabetes Society. China Guideline For Type 2 Diabetes (2010 Ed). (2012). Chin J Diabetes 20, S1–S36.Google Scholar
  9. Chinese Diabetes Society. China Guideline For Type 2 Diabetes (2013 Ed). (2014). Chin J Diabetes Mellitus 6, 447–498.Google Scholar
  10. Chiu, M., Austin, P.C., Manuel, D.G., Shah, B.R., and Tu, J.V. (2011). Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 34, 1741–1748.Google Scholar
  11. Cui, B., Zhu, X., Xu, M., Guo, T., Zhu, D., Chen, G., Li, X., Xu, L., Bi, Y., Chen, Y., et al. (2011). A genome-wide association study confirms previously reported loci for type 2 diabetes in Han Chinese. PLoS ONE 6, e22353.Google Scholar
  12. Cui, G., Zhang, Y., Gong, Z., Zhang, J.Z., and Zang, Y.Q. (2009). Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes. Cell Res 19, 574–583.Google Scholar
  13. Dagogo-Jack, S. (2010). Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol 6, 589–593.Google Scholar
  14. Dong, B., Yu, Q.T., Dai, H.Y., Gao, Y.Y., Zhou, Z.L., Zhang, L., Jiang, H., Gao, F., Li, S.Y., Zhang, Y.H., et al. (2012). Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J Am College Cardiol 59, 739–747.Google Scholar
  15. Dong, X., He, M., Song, X., Lu, B., Yang, Y., Zhang, S., Zhao, N., Zhou, L., Li, Y., Zhu, X., et al. (2007). Performance and comparison of the Cockcroft-Gault and simplified Modification of Diet in Renal Disease formulae in estimating glomerular filtration rate in a Chinese Type 2 diabetic population. Diabetic Med 24, 1482–1486.Google Scholar
  16. Feng, R., Li, K., Cheng, J., Xie, S., Chai, J., Wei, P., and Wang, D. (2013). Toward integrated and sustainable prevention against diabetes in rural China: study rationale and protocol of eCROPS. BMC Endocr Disord 13, 28.Google Scholar
  17. Flegal, K.M., Carroll, M.D., Kit, B.K., and Ogden, C.L. (2012). Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307, 491–497.Google Scholar
  18. Fox, C.S., Golden, S.H., Anderson, C., Bray, G.A., Burke, L.E., de Boer, I. H., Deedwania, P., Eckel, R.H., Ershow, A.G., Fradkin, J., et al. (2015). Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38, 1777–1803.Google Scholar
  19. Geiss, L.S., Wang, J., Cheng, Y.J., Thompson, T.J., Barker, L., Li, Y., Albright, A.L., and Gregg, E.W. (2014). Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA 312, 1218–1226.Google Scholar
  20. Gong, Q., Gregg, E.W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., et al. (2011). Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54, 300–307.Google Scholar
  21. Gregg, E.W., Li, Y., Wang, J., Rios Burrows, N., Ali, M.K., Rolka, D., Williams, D.E., and Geiss, L. (2014). Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370, 1514–1523.Google Scholar
  22. Gu, D., Reynolds, K., Duan, X., Xin, X., Chen, J., Wu, X., Mo, J., Whelton, P.K., He, J., and He, J. (2003). Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46, 1190–1198.Google Scholar
  23. Gu, W., Hu, J., Wang, W., Li, L., Tang, W., Sun, S., Cui, W., Ye, L., Zhang, Y., Hong, J., et al. (2012). Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care 35, 1413–1419.Google Scholar
  24. Gu, Y., Wang, X., Li, J., Zhang, Y., Zhong, H., Liu, R., Zhang, D., Feng, Q., Xie, X., Hong, J., et al. (2017). Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun 8, 1785.Google Scholar
  25. Gu, Y., Zhang, Y., Shi, X., Li, X., Hong, J., Chen, J., Gu, W., Lu, X., Xu, G., and Ning, G. (2010). Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 81, 766–772.Google Scholar
  26. He, A., Zhu, L., Gupta, N., Chang, Y., and Fang, F. (2007). Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3t3-l1 adipocytes. Mol Endocrinol 21, 2785–2794.Google Scholar
  27. Hong, J., Zhang, Y., Lai, S., Lv, A., Su, Q., Dong, Y., Zhou, Z., Tang, W., Zhao, J., Cui, L., et al. (2013). Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes Care 36, 1304–1311.Google Scholar
  28. Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., and Qin, Y. (2006). Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR? pathway. Biochem Biophys Res Commun 348, 571–578.Google Scholar
  29. International Diabetes Federation. IDF Diabetes Atlas, 8th ed. (2017). Brussels, Belgium: International Diabetes Federation.Google Scholar
  30. Ji, L., Hu, D., Pan, C., Weng, J., Huo, Y., Ma, C., Mu, Y., Hao, C., Ji, Q., and Ran, X. (2013). Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med 126, 925.e911–925.e922.Google Scholar
  31. Ji, L., Ma, J., Li, H., Mansfield, T.A., T’joen, C.L., Iqbal, N., Ptaszynska, A., and List, J.F. (2014). Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study. Clin Therapeut 36, 84–100.e9.Google Scholar
  32. Ji, L., Tong, X., Wang, H., Tian, H., Zhou, H., Zhang, L., Li, Q., Wang, Y., Li, H., Liu, M., et al. (2013). Efficacy and safety of traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial. PLoS ONE 8, e56703.Google Scholar
  33. Jia, W., Xiao, X., Ji, Q., Ahn, K.J., Chuang, L.M., Bao, Y., Pang, C., Chen, L., Gao, F., Tu, Y., et al. (2015). Efficacy and safety of traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol 3, 254–262.Google Scholar
  34. Jiang, H., Chen, W., Bi, K., and Ying, X. (2009). Are services delivered by community health centers more cost-effective? Evidence from urban China. Health Econ 18, S107–S117.Google Scholar
  35. Jiang, W., Shi, Y., Zhao, D., Chen, S., Yong, J., Zhang, J., Qing, T., Sun, X., Zhang, P., Ding, M., et al. (2007). In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res 17, 333–344.Google Scholar
  36. Leng, J., Shao, P., Zhang, C., Tian, H., Zhang, F., Zhang, S., Dong, L., Li, L., Yu, Z., Chan, J.C.N., et al. (2015). Prevalence of gestational diabetes mellitus and its risk factors in Chinese pregnant women: a prospective population-based study in Tianjin, China. PLoS ONE 10, e0121029.Google Scholar
  37. Leng, S., Lu, F., and Xu, L. (2004). Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25, 496–502.Google Scholar
  38. Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E.W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014). Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2, 474–480.Google Scholar
  39. Li, G., Zhang, P., Wang, J., Gregg, E.W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008). The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371, 1783–1789.Google Scholar
  40. Li, H., Gan, W., Lu, L., Dong, X., Han, X., Hu, C., Yang, Z., Sun, L., Bao, W., Li, P., et al. (2013). A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes 62, 291–298.Google Scholar
  41. Li, J., Yang, D., Yan, J., Huang, B., Zhang, Y., Weng, J., and Weng, J. (2014). Secondary diabetic ketoacidosis and severe hypoglycaemia in patients with established type 1 diabetes mellitus in china: a multicentre registration study. Diabetes Metab Res Rev 30, 497–504.Google Scholar
  42. Li, W., Zhang, S., Liu, H., Wang, L., Zhang, C., Leng, J., Yu, Z., Yang, X., Tian, H., and Hu, G. (2014). Different associations of diabetes with β-cell dysfunction and insulin resistance among obese and nonobese chinese women with prior gestational diabetes mellitus. Diabetes Care 37, 2533–2539.Google Scholar
  43. Li, Y., Xu, W., Liao, Z., Yao, B., Chen, X., Huang, Z., Hu, G., and Weng, J. (2004). Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care 27, 2597–2602.Google Scholar
  44. Lian, F., Li, G., Chen, X., Wang, X., Piao, C., Wang, J., Hong, Y., Ba, Z., Wu, S., Zhou, X., et al. (2014). Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 99, 648–655.Google Scholar
  45. Liao, S., Mei, J., Song, W., Liu, Y., Tan, Y.D., Chi, S., Li, P., Chen, X., and Deng, S. (2014). The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women. Diabet Med 31, 341–351.Google Scholar
  46. Lin, J., Zhou, Z.G., Wang, J.P., Zhang, C., and Huang, G. (2008). From type 1, through LADA, to type 2 diabetes: a continuous spectrum? Ann New York Acad Sci 1150, 99–102.Google Scholar
  47. Lin, S., Han, Y., Shi, Y., Rong, H., Zheng, S., Jin, S., Lin, S.Y., Lin, S.C., and Li, Y. (2012). Revealing a steroid receptor ligand as a unique PPAR? agonist. Cell Res 22, 746–756.Google Scholar
  48. Liu, F., Song, R., Feng, Y., Guo, J., Chen, Y., Zhang, Y., Chen, T., Wang, Y., Huang, Y., Li, C.Y., et al. (2015). Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor a. Circulation 131, 795–804.Google Scholar
  49. Liu, L., Furuta, H., Minami, A., Zheng, T., Jia, W., Nanjo, K., and Xiang, K. (2007). A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family. Mol Cell Biochem 303, 115–120.Google Scholar
  50. Lu, B., Song, X., Dong, X., Yang, Y., Zhang, Z., Wen, J., Li, Y., Zhou, L., Zhao, N., Zhu, X., et al. (2008). High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes its Complications 22, 96–103.Google Scholar
  51. Lu, B., Wen, J., Song, X.Y., Dong, X.H., Yang, Y.H., Zhang, Z.Y., Zhao, N. Q., Ye, H.Y., Mou, B., Chen, F.L., et al. (2007). High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Practice 75, 184–192.Google Scholar
  52. Lu, Z., Pan, C., Gao, Y., Guo, L., Ning, G., Liu, Z., Lu, J., Jia, P., Wang, X., Sun S, et al. (2011). A randomized, double blind, placebo-controlled, parallel and multicenter study to evaluate the safety and efficacy of pioglitazone with sulphonylurea in type 2 diabetic patients (in Chinese). Zhonghua Nei Ke Za Zhi 50, 826–830.Google Scholar
  53. Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J., and Pei, G. (2009). Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance. Nature 457, 1146–1149.Google Scholar
  54. Luo, T.H., Zhao, Y., Li, G., Yuan, W.T., Zhao, J.J., Chen, J.L., Huang, W., and Luo, M. (2001). A genome-wide search for type ii diabetes susceptibility genes in Chinese Hans. Diabetologia 44, 501–506.Google Scholar
  55. Mayer-Davis, E.J., Lawrence, J.M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D.J., et al. (2017). Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med 377, 301.Google Scholar
  56. Meng, Z.X., Nie, J., Ling, J.J., Sun, J.X., Zhu, Y.X., Gao, L., Lv, J.H., Zhu, D.Y., Sun, Y.J., and Han, X. (2009). Activation of liver x receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 52, 125–135.Google Scholar
  57. Mu, P., Chen, Y., Lu, H., Wen, X., Zhang, Y., Xie, R., Shu, J., Wang, M., and Zeng, L. (2012). Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes. Diabetes Metab Res Rev 28, 236–240.Google Scholar
  58. Nathan, D.M., Genuth, S., Lachin, J., Cleary, P., Crofford, O., Davis, M., Rand, L., and Siebert, C. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329, 977–986.Google Scholar
  59. National Institute of Health. Glossay of NIH terms. https://doi.org/grants.nih.gov/grants/glossary.htm#C, 2017-04-04. National Science Foundation. What is Basic Science. https://doi.org/www.nsf.gov/pubs/1953/annualreports/ar_1953_sec6.pdf https://doi.org/grants.nih.gov/grants/glossary.htm#C, 2017-04-04. National Science Foundation. What is Basic Science. https://doi.org/www.nsf.gov/pubs/1953/annualreports/ar_1953_sec6.pdf, 2017-04-04.
  60. NCD Risk Factor Collaboration (NCD-RisC). (2016). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet 387, 1513–1530.Google Scholar
  61. Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., and Shichiri, M. (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Practice 28, 103–117.Google Scholar
  62. Pan, X., Li, G., Hu, Y., Wang, J., Yang, W., An, Z., Hu, Z., Lin, J., Xiao, J., Cao, H., et al. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537–544.Google Scholar
  63. Pan, X.R., Yang, W.Y., Li, G.W., and Liu, J. (1994). Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 20, 1664–1669.Google Scholar
  64. Pang, S., Tang, H., Zhuo, S., Zang, Y.Q., and Le, Y. (2010). Regulation of fasting fuel metabolism by Toll-Like Receptor 4. Diabetes 59, 3041–3048.Google Scholar
  65. Patterson, C.C., Dahlquist, G.G., Gyürüs, E., Green, A., and Soltész, G. (2009). Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373, 2027–2033.Google Scholar
  66. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60.Google Scholar
  67. Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014). Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59–64.Google Scholar
  68. Qin, X., Xie, X., Fan, Y., Tian, J., Guan, Y., Wang, X., Zhu, Y., and Wang, N. (2008). Peroxisome proliferator-activated receptor-d induces insulininduced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology 48, 432–441.Google Scholar
  69. Shang, M., and Lin, L. (2014). IADPSG criteria for diagnosing gestational diabetes mellitus and predicting adverse pregnancy outcomes. J Perinatol 34, 100–104.Google Scholar
  70. Shen, Y., Cai, M., Liang, H., Wang, H., and Weng, J. (2011). Insight into the biochemical characteristics of a novel glucokinase gene mutation. Hum Genet 129, 231–238.Google Scholar
  71. Shi, Y., Hou, L., Tang, F., Jiang, W., Wang, P., Ding, M., and Deng, H. (2005). Inducing embryonic stem cells to differentiate into pancreatic β cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 23, 656–662.Google Scholar
  72. Shrestha, C., He, H., Liu, Y., Zhu, S., Xiong, J., and Mo, Z. (2013). Changes in adipokines following laparoscopic Roux-en-Y gastric bypass surgery in Chinese individuals with type 2 diabetes mellitus and BMI of 22–30 kg m-2. Int J Endocrinol 2013, 1–6.Google Scholar
  73. Song, R., Peng, W., Zhang, Y., Lv, F., Wu, H.K., Guo, J., Cao, Y., Pi, Y., Zhang, X., Jin, L., et al. (2013). Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature 494, 375–379.Google Scholar
  74. Sun, J., Furio, L., Mecheri, R., van der Does, A.M., Lundeberg, E., Saveanu, L., Chen, Y., van Endert, P., Agerberth, B., and Diana, J. (2015). Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43, 304–317.Google Scholar
  75. Tang, L.Q., Wei, W., Chen, L.M., and Liu, S. (2006). Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108, 109–115.Google Scholar
  76. The Lancet. Ageing in China: a ticking bomb. (2016}). The Lancet 388, 2058Google Scholar
  77. Thomson Reuters. Essential Science Indicators. https://doi.org/esi.incites.thomsonreuters.com/, 2017-06-23.
  78. Thomson Reuters. Journal Citation Report. https://doi.org/jcr.incites.thomsonreuters.com/JCRJournalHomeAction.action, 2016-08-24.
  79. UNESCO Institute for Statistics. UNESCO eAtlas of Research and Experimental Development. https://doi.org/www.tellmaps.com/uis/rd/#!/topic/RD, 2017-04-04.
  80. Van Noorden, R. (2016). China by the numbers. Nature 534, 452–453.Google Scholar
  81. Wang, C., Fang, Q., Zhang, R., Lin, X., and Xiang, K. (2004). Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees. Acta Diabetol 41, 137–145.Google Scholar
  82. Wang, F.H., Liang, Y.B., Zhang, F., Wang, J.J., Wei, W.B., Tao, Q.S., Sun, L.P., Friedman, D.S., Wang, N.L., and Wong, T.Y. (2009). Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 116, 461–467.Google Scholar
  83. Wang, G., Liu, J., Yang, N., Gao, X., Fan, H., Xu, Y., and Yang, W. (2014). MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patients. PLoS ONE 9, e105698.Google Scholar
  84. Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., Li, Y., Zhao, Z., Qin, X., Jin, D., et al. (2017). Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 317, 2515.Google Scholar
  85. Wang, W., Fu, C.W., Pan, C.Y., Chen, W., Zhan, S., Luan, R., Tan, A., Liu, Z., and Xu, B. (2009). How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 12, 923–929.Google Scholar
  86. Wang, W., Fu, C., Zhuo, H., Luo, J., and Xu, B. (2010). Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China. BMC Health Serv Res 10, 244.Google Scholar
  87. Wang, X.H., Qian, R.Z., Zhang, W., Chen, S.F., Jin, H.M., and Hu, R.M. (2009). microRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36, 181–188.Google Scholar
  88. Wei, Y., Yang, H., Zhu, W., Yang, H., Li, H., Yan, J., and Zhang, C. (2014). International Association of Diabetes and Pregnancy Study Group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China. Chin Med J (Engl) 127, 3553–3556.Google Scholar
  89. Weng, J.P., and Hu, G. (2017). Diabetes: leveraging the tipping point of the diabetes pandemic. Diabetes 66, 1461–1463.Google Scholar
  90. Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008). Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371, 1753–1760.Google Scholar
  91. Weng, J., Retnakaran, R., Ariachery C, A., Ji, L., Meneghini, L., Yang, W., and Woo, J.T. (2015). Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps. Diabetes Metab Res Rev 31, 537–544.Google Scholar
  92. Wu, X.K., Stener-Victorin, E., Kuang, H.Y., Ma, H.L., Gao, J.S., Xie, L.Z., Hou, L.H., Hu, Z.X., Shao, X.G., Ge, J., et al. (2017). Effect of acupuncture and clomiphene in chinese women with polycystic ovary syndrome. JAMA 317, 2502–2514.Google Scholar
  93. Wu, Y., Li, H., Loos, R.J.F., Yu, Z., Ye, X., Chen, L., Pan, A., Hu, F.B., and Lin, X. (2008). Common variants in cdkal1, cdkn2a/b, igf2bp2, slc30a8, and hhex/ide genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 57, 2834–2842.Google Scholar
  94. Xiang, K., Wang, Y., Zheng, T., Jia, W., Li, J., Chen, L., Shen, K., Wu, S., Lin, X., Zhang, G., et al. (2004). Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21- q24. Diabetes 53, 228–234.Google Scholar
  95. Xie, X.W., Xu, L., Wang, Y.X., and Jonas, J.B. (2008). Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol 246, 1519–1526.Google Scholar
  96. Xu, F., Li, Z., Zheng, X., Liu, H., Liang, H., Xu, H., Chen, Z., Zeng, K., and Weng, J. (2014). SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Diabetes 63, 3637–3646.Google Scholar
  97. Xu, J.Y., Dan, Q.H., Chan, V., Wat, N.M.S., Tam, S., Tiu, S.C., Lee, K.F., Siu, S.C., Tsang, M.W., Fung, L.M., et al. (2005). Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Eur J Hum Genet 13, 422–427.Google Scholar
  98. Xu, W., Bi, Y., Sun, Z., Li, J., Guo, L., Yang, T., Wu, G., Shi, L., Feng, Z., Qiu, L., et al. (2015). Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study). J Intern Med 277, 137–150.Google Scholar
  99. Xu, W., Li, Y., Deng, W., Hao, Y., and Weng, J. (2009). Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study. Chin Med J (Engl) 122, 2554–2559.Google Scholar
  100. Xu, Y., Wang, L., He, J., Bi, Y., Li, M., Wang, T., Wang, L., Jiang, Y., Dai, M., Lu, J., et al. (2013). Prevalence and control of diabetes in Chinese adults. JAMA 310, 948.Google Scholar
  101. Yan, H., Tang, L., Chen, T., Kral, J.G., Jiang, L., Li, Y., Hu, R., Cui, J., Li, S., and Tian, F. (2013). Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass. Obes Facts 6, 176–184.Google Scholar
  102. Yang, H., Wei, Y., Gao, X., Xu, X., Fan, L., He, J., Hu, Y., Liu, X., Chen, X., Yang, Z., et al. (2009). Risk factors for gestational diabetes mellitus in Chinese women-a prospective study of 16,286 pregnant women in China. Diabetic Med 26, 1099–1104.Google Scholar
  103. Yang, J., Wang, C., Cao, G., Yang, W., Yu, S., Zhai, H., and Pan, Y. (2015). Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28–35 kg/m2. BMC Surg 15, 88.Google Scholar
  104. Yang, L., Christensen, T., Sun, F., and Chang, J. (2012). Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study. Value Health 15, S56–S59.Google Scholar
  105. Yang, W., Chen, L., Ji, Q., Liu, X., Ma, J., Tandon, N., Bhattacharyya, A., Kumar, A., Kim, K.W., Yoon, K.H., et al. (2011). Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, doubl. Diabetes Obesity Metab 13, 81–88.Google Scholar
  106. Yang, W., Liu, J., Shan, Z., Tian, H., Zhou, Z., Ji, Q., Weng, J., Jia, W., Lu, J., Liu, J., et al. (2014). Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol 2, 46–55.Google Scholar
  107. Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010). Prevalence of diabetes among men and women in China. N Engl J Med 362, 1090–1101.Google Scholar
  108. Yang, W., Zhao, W., Xiao, J., Li, R., Zhang, P., Kissimova-Skarbek, K., Schneider, E., Jia, W., Ji, L., Guo, X., et al. (2012). Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS ONE 7, e39513.Google Scholar
  109. Yang, Z., Wang, K., Li, T., Sun, W., Li, Y., Chang, Y.F., Dorman, J.S., and LaPorte, R.E. (1998). Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care 21, 525–529.Google Scholar
  110. Yang, Z., Wu, S., Zheng, T., Lu, H., and Xiang, K. (2006). Identification of four novel mutations in the HNF-1A gene in Chinese early-onset and/or multiplex diabetes pedigrees. Chin Med J (Engl) 119, 1072–1078.Google Scholar
  111. Yin, J., Xing, H., and Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57, 712–717.Google Scholar
  112. Yu, H., Di, J., Bao, Y., Zhang, P., Zhang, L., Tu, Y., Han, X., and Jia, W. (2015). Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2. Surgery Obesity Related Dis 11, 6–11.Google Scholar
  113. Zhang, F., Dong, L., Zhang, C.P., Li, B., Wen, J., Gao, W., Sun, S., Lv, F., Tian, H., Tuomilehto, J., et al. (2011). Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabetic Med 28, 652–657.Google Scholar
  114. Zhang, H., Wei, J., Xue, R., Wu, J.D., Zhao, W., Wang, Z.Z., Wang, S.K., Zhou, Z.X., Song, D.Q., Wang, Y.M., et al. (2009). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59, 285–292.Google Scholar
  115. Zhang, J., and Chaaban, J. (2013). The economic cost of physical inactivity in China. Prevent Med 56, 75–78.Google Scholar
  116. Zhang, L., Wang, Z., Qian, D., and Ni, J. (2014). Effects of changes in health insurance reimbursement level on outpatient service utilization of rural diabetics: evidence from Jiangsu Province, China. BMC Health Serv Res 14, 185.Google Scholar
  117. Zhang, M., Lv, X.Y., Li, J., Xu, Z.G., and Chen, L. (2008). The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008, 1–9.Google Scholar
  118. Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., et al. (2014). Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 63, 514–525.Google Scholar
  119. Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93, 2559–2565.Google Scholar
  120. Zhao, W., Zhai, Y., Hu, J., Wang, J., Yang, Z., Kong, L., and Chen, C. (2008). Economic burden of obesity-related chronic diseases in Mainland China. Obesity Rev 9, 62–67.Google Scholar
  121. Zhao, X., Guo, L., Yuan, M., He, X., Lin, Y., Gu, C., Li, Q., Zhao, L., and Tong, X. (2016). Growing trend of China's contribution to global diabetes research. Medicine 95, e3517.Google Scholar
  122. Zhong, X.L. (1982). Diabetes mellitus survey in China. Chin Med J 95, 423.Google Scholar
  123. Zhou, J., Li, H., Ran, X., Yang, W., Li, Q., Peng, Y., Li, Y., Gao, X., Luan, X., and Wang, W. (2011). Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit 17, CR9.Google Scholar
  124. Zhou, J., Li, H., Ran, X., Yang, W., Li, Q., Peng, Y., Li, Y., Gao, X., Luan, X., Wang, W., et al. (2009). Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care 32, 1188–1193.Google Scholar
  125. Zhou, J., Lv, X., Mu, Y., Wang, X., Li, J., Zhang, X., Wu, J., Bao, Y., and Jia, W. (2012). The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study. Diabetes Tech Therapeut 14, 710–718.Google Scholar
  126. Zhu, L., Mo, Z., Yang, X., Liu, S., Wang, G., Li, P., Tan, J., Ye, F., Strain, J., Im, I., et al. (2012). Effect of laparoscopic Roux-en-Y gastroenterostomy with BMI <35 kg/m2 in type 2 diabetes mellitus. Obes Surg 22, 1562–1567.Google Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of DiabetologyThe Third Affiliated Hospital of Sun Yat-Sen UniversityGuangzhouChina
  2. 2.Department of PhysiologyUniversity of TorontoTorontoCanada

Personalised recommendations